A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

• Status: Completed
• Trial end date: 2015-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

A phase I, Open-label, Randomized, Single-dose, 2 x 2 Crossover Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet and Coadministration of Fimasartan and Atorvastatin as Individual Tablets in Healthy Male Volunteers.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Boryung Pharmaceutical Co., Ltd
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• a Healthy male subject, aged 19- 50 years

Exclusion Criteria:

• History of clinically significant hypersensitivity to study drug, any other drug

• Hypotension or hypertension

• Active liver disease

• History of gastrointestinal disease

• History of excessive alcohol abuse

• Participation in any other study within 3 months